The effect of surgical weight loss on obstructive sleep apnoea: A
systematic review and meta-analysis
SUPPLEMENTARY DATA
Ai-Ming Wong1,2, Hayley N. Barnes3, Simon A. Joosten1,2, Shane A. Landry4, Eli Dabscheck3,5, Darren R. Mansfield1,6, Shyamali C. Dharmage7, Chamara V. Senaratna7,8, Bradley A. Edwards4*, Garun S. Hamilton1,2*
*These authors jointly supervised this work.
1Monash Lung and Sleep, Monash Health, Monash Medical Centre, Melbourne, Australia, 2School of Clinical Sciences, Monash
University, Melbourne, Australia, 3Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Melbourne
Victoria 3004, Australia, 4Department of Physiology and School of Psychological Sciences, Monash University, Melbourne,
Australia, 5Central Clinical School, Monash University, Melbourne, Australia, 6School of Psychological Sciences and Monash
Institute of Cognitive and Clinical Neurosciences, Monash University, Victoria, Australia, 7Allergy and Lung Health Unit, Centre
for Epidemiology & Biostatistics, Melbourne School of Population & Global Health, Victoria 3010, Australia, 8University of Sri
Jayewardenepura, Nugegoda, Sri Lanka.
- Running Head: “Effect of surgical weight loss on OSA”
- Word count: 3904
- Corresponding Author:
Associate Professor Garun HamiltonMonash Lung and Sleep, Monash Medical Centre, 246 Clayton Road,Clayton 3168, Victoria, AustraliaPh: +61 3 95946666Fax: +61 3 95946811Email: [email protected]
SUPPLEMENTARY RESULTS
Additional results from the systematic review
There were a number of interesting observations upon reviewing the 27 studies included in
the systematic review which were not able to be covered in the main manuscript due to
limited space. Hence, we present some of the interesting results in this section, focussing in
particular on: a) surgical vs non-surgical weight loss interventions in non-randomised
controlled trials (non-RCTs), b) positional obstructive sleep apnoea (OSA), and c) impact of
gender on OSA in participants undergoing bariatric surgery.
a) Non-RCTs comparing surgical and non-surgical weight loss interventions
One non-RCT comparing the effects of surgical weight loss (gastric banding or gastric
bypass) with continuous positive airway pressure (CPAP) reported a greater reduction in
median apnoea-hypopnoea index (AHI) and body mass index (BMI) in the bariatric surgery
group [1]. The surgical group had a significant reduction in median BMI (from 43.7 kg/m² to
28.3 kg/m²) over 12 to 18 months compared with the CPAP group (from 33.8 kg/m² to 34.2
kg/m²), and the AHI also improved in the surgical group (from 18.1 events/h to 6.5 events/h).
The AHI reported in the CPAP group was performed with CPAP, showing a significant
reduction from baseline (from 36.5 to 3.8 events/h).
Another non-RCT [2] comparing the effects of surgical weight loss (Roux-en-Y gastric
bypass [RYGB]) with an intensive lifestyle intervention (participants underwent a one-year
lifestyle program at a rehabilitation centre) showed that RYGB was more effective at
reducing the severity of OSA with a mean between-group difference AHI of 7.2 events/h
(95%CI 4.4, 21.2). The bariatric surgery group also had lower odds of OSA at one year.
However, after adding the change in BMI that occurred with weight loss to this model, there
was no significant difference seen based on the treatment group assigned. This supports the
notion that any reduction in OSA severity associated with bariatric surgery is related to
weight loss and is otherwise independent from the type of surgical procedure.
b) Positional OSA
Two before-and-after studies had reported both supine and non-supine AHI [2, 3], however,
only one study [4] reported the percent of total sleep time spent in the supine position. Given
the lack of certainty regarding the amount of time spent in supine and non-supine sleep
across all studies, we did not feel it was appropriate to perform quantitative analysis.
Weight loss appeared to reduce the non-supine AHI more significantly than supine AHI in
both studies, with no or minimal non-supine OSA evident post-surgery (supine AHI dropped
from 41.5 to 12.2 events/h in Fredheim et al. [2], and from 32.1 to 15.8 events/h in Peromaa-
Haavisto et al. [3]; non-supine AHI dropped from 25.9 to 3.1 events/h in Fredheim et al. [2],
and from 24.4 to 6.3 events/h in Peromaa-Haavisto et al. [3]).
Another study aimed to determine the prevalence of positional OSA in patients undergoing
bariatric surgery [4]. They used the Cartwright’s definition for positional OSA (i.e. supine AHI
≥ 2 times non-supine AHI) [5], however, patients could have spent between 10 – 90% of
sleep in the supine position to be considered in the study. No pre- and post-surgery supine
and non-supine AHIs were available for review. The prevalence of positional OSA after
bariatric surgery in their study cohort was 62.7%. In the final analysis, 35.2% (32/91 patients)
no longer had OSA after surgery.
c) Impact of gender on OSA in participants undergoing bariatric surgery
Only one study examined the influence that gender has on bariatric surgery outcomes [6].
Lettieri et al. reported that men had higher baseline AHIs, experienced larger absolute
reductions (49.5 ± 26.7 events/h vs 14.7 ± 13.5 events/h, p<0.001) as well as higher relative
reductions in AHI compared to women. Furthermore, despite less dramatic reductions in AHI
than men, women had less severe disease at the post-surgery sleep study and were more
likely to be classified in milder OSA categories than men.
Another study that had been identified in our initial search but was not included in the final
meta-analysis (due to suspected overlap with another publication from the same author
group) did explore the effect of gender on obesity indices, metabolic outcomes and sleep
parameters in patients with OSA, obesity and type 2 diabetes mellitus (T2DM) after
laparoscopic RYGB [7]. In 35 participants, there were no significant differences in pre- and
post-surgery AHI or BMI, or the change in AHI and BMI associated with surgery [8]. Overall,
there was very limited evidence examining the impact that gender has on OSA outcomes
following surgery. As such, more data will be required in order to determine the robustness
of the available evidence.
Additional results from the meta-analysis
a) Impact of bariatric surgery on oxygen desaturation index 4% (ODI4%)
In addition to reporting the changes in AHI, four studies also reported pre- and post-surgery
ODI (another marker of OSA severity), however, only three (94 participants) could be meta-
analysed as they used the same oxygen desaturation definition of ≥4% [7, 9, 10]. The WMD
for change in ODI4% was -28.8 events/h (95%CI -46.3, -11.4) with a high I²=95.2%.
b) Individual participant data - subgroup analysis (gender)
We performed sub-group analysis based on gender in the bariatric surgery group (n=39) at
one-year post randomisation [11, 12]. Males were more overweight and had higher pre-
surgery AHI than females, however, there was no significant difference in mean change of
AHI, BMI and weight apart from a slightly higher percent change reduction in AHI in females
(males: -43.9%, females: -56.0%) despite a slightly lower percent change reduction in BMI
(males: -18.9%, females: -17.0%). In this group of participants, more men still had severe
OSA at one-year post randomisation compared with women (53% (10/19) vs 20% (4/20)).
DISCUSSION
CPAP vs bariatric surgery for treatment of OSA
CPAP is the gold standard treatment for OSA. A recent RCT comparing bariatric surgery and
CPAP showed that bariatric surgery may be a reasonable alternative to CPAP [13].
However, there was a large crossover of patients (50%) from the bariatric surgery group to
the CPAP group, suggesting that it may not be an acceptable therapy to all-comers. It was
also interesting to note that the CPAP group lost weight (approximately mean 5kg) over an
18-month period, contrary to a recent meta-analysis of 25 RCTs and 3181 patients [14]
suggesting that OSA treatment with CPAP promotes weight gain of approximately 0.42 kg
over a median of three months. Perhaps the patient group in the study by Bakker et al. were
a more selected group who were “primed” to lose weight, given the potential for
randomisation into a bariatric surgery arm.
The authors also introduced a new parameter called the “Effective AHI”, which takes into
account the number of sleep disordered breathing events both when the patient is asleep
with CPAP and when the patient is asleep but not using CPAP [15]. This parameter is an
example of the application of a tool to measure the effectiveness of OSA treatment. The
effectiveness of OSA treatment is important because it takes into consideration both the
efficacy (i.e. the ability of the treatment to overcome airway collapse) as well as the time
course over which the treatment is being used (i.e. adherence) and gives a better sense of
overall OSA control [16, 17]. Tools to measure the “Effective AHI” as suggested by Bakker et
al. [13] may also be used to facilitate comparison of OSA treatment effectiveness across
OSA treatment modalities as has been demonstrated by other investigators, such as
Sutherland et al. [16]. These sorts of tools could help with deciphering which OSA treatment
would prove to be most beneficial to a particular patient based on the efficacy of the
treatment as well as the patient’s ability to tolerate and comply with the treatment in question
(e.g. CPAP versus mandibular advancement splint [16]).
SUPPLEMENTARY DATA FIGURES
Fig. S1. Pre-surgery compared to post-surgery for the primary outcome of ∆weight (kg) forest plot. SD: standard deviation, CI: confidence interval. Note that these studies are referenced based on the reference list in the main manuscript.
Fig. S2. Bubble plot of weighted mean difference for change in AHI versus follow-up duration (time between surgery and post-surgery sleep study). AHI: apnoea-hypopnoea index (events/h); WMD: weighted mean difference for change in AHI (events/h).
Fig. S3. Bubble plot of weighted mean difference for change in BMI versus follow-up duration (time between surgery and post-surgery sleep study). BMI: body mass index (kg/m²); WMD: weighted mean difference for change in BMI (kg/m²).
Fig. S4. Individual participant data (bariatric surgery group) from two RCTs [11, 12] – Percentage (%) of participants with OSA and distribution of severity of OSA at each time-point [baseline, 1y follow-up and 2nd follow-up (i.e. 2y for Dixon et al. [11] and 3y for Feigel-Guiller et al. [12])]. All participants must have had a baseline and 1y follow-up sleep study to be included in this graph. OSA: obstructive sleep apnoea; RCT: randomised controlled trial.
Fig. S5. Individual participant data (bariatric surgery group) from two RCTs [11, 12] – AHI at baseline, 1y follow-up and second follow-up (i.e. 2y for Dixon et al. [11] in Fig. S5a and 3y for Feigel-Guiller et al. [12] in Fig. S5b)]. All participants must have had a baseline and 1y follow-up sleep study to be included in this graph. AHI: apnoea-hypopnoea index (events/h); OSA: obstructive sleep apnoea; RCT: randomised controlled trial.
Fig. S6. Individual participant data (bariatric surgery group) from two RCTs [11, 12] – Weight (kg) at baseline, 1y follow-up and second follow-up (i.e. 2y for Dixon et al.[11] in Fig. S6a and 3y for Feigel-Guiller et al.[12] in Fig. S6b)]. All participants must have had a baseline and 1y follow-up sleep study to be included in this graph. OSA: obstructive sleep apnoea; RCT: randomised controlled trial.
Fig. S7a. Individual participant data (bariatric surgery group) from two RCTs [11, 12] – AHI and weight at one year. There is no relationship between the amount of weight loss and the improvement in AHI at one year. AHI: apnoea-hypopnoea index (events/h); RCT: randomised controlled trial.
Fig. S7b. Individual participant data (bariatric surgery group) from two RCTs [11, 12] – AHI and BMI at one year. There is no relationship between the reduction in BMI and the improvement in AHI at one year. AHI: apnoea-hypopnoea index (events/h); BMI: body mass index (kg/m²); RCT: randomised controlled trial.
SUPPLEMENTARY DATA TABLES
Table S1
Quality of before-and-after studies using the Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group developed by the National Heart, Lung, and Blood Institute [18].
Study General
rating
Study notes
Aguiar et al. 2014 [19] Good
Bae et al. 2014 [20] Fair Possible selection bias. Only 10/67(15%) eligible
participants had post-surgery PSG.
da Silva et al. 2013 [21] Fair Possible selection bias with 18 participants not
contacted; >20% lost to follow-up
Del Genio et al. 2016 [22] Good
de Raaff et al. 2016 [23] Fair >50% lost to follow-up but also had a large
sample size
Dixon et al. 2005 [24] Good Only 27/49(55%) eligible participants agreed to
have the follow-up PSG. Despite this, the authors
did account for the lost to follow-up.
Fritscher et al. 2007 [25] Fair Possible selection bias: 128 bariatric surgeries
performed, only 20 participants had a PSG prior
surgery to investigate for subjective daytime
somnolence symptoms. Subsequently, 18 had
OSAS, hence were recruited into the study.
Guardiano et al. 2003 [26] Fair >50% lost to follow-up. Small sample size (28
offered but only eight had follow-up PSG)
Haines et al. 2007 [27] Good Despite >20% lost to follow-up, authors did
account for drop out (101/179 participants had
post-surgery PSG). There was also a relatively
larger sample size of patients for review.
Krieger et al. 2012 [28] Good Individual participant data provided by author.
Lettieri et al. 2008 [6] Good
Morong et al. 2014 [4] Good
Pallayova et al. 2011 [29] Good
Peromaa-Haavisto et al.
2017 [3]
Good Type 3 PG used.
Priyadarshini et al. 2017
[30]
Good
Rao et al. 2009 [31] Fair Possible selection bias. Patients with OSA were
randomly offered post-surgery PSG.
Ravesloot et al. 2014 [32] Good Despite >36% lost to follow-up, they were
accounted for. There was reasonable sample
size (171 participants pre-surgery had OSA on
PSG, 110 patients had 1st post-surgery PSG, 50
participants had 2nd post-surgery PSG).
Shaarawy et al. 2016 [9] Fair Small sample size (n=22) and no statistical
power was given.
Suliman et al. 2016 [33] Fair 36% were lost to follow-up and small sample size
(n=20).
Valencia-Flores et al.
2004 [10]
Fair Possible selection bias. 29/65(45%) referred
participants accepted 2nd invitation for
follow-up/post-surgery PSG. No particular sample
size given.
Xie et al. 2016 [34] Poor Small sample size had repeat PSG, and follow-
up PSG was offered at random. Only 15 of 167
participants had both pre- and post-surgery PSG.
Zou et al. 2015 [7] Good Well-designed study hence rated “Good”.
Potential selection bias as participants included
had to have both obesity and Type 2 Diabetes
Mellitus.
1st: first; 2nd: second; PG: polygraphy; PSG: polysomnography; OSAS: obstructive sleep
apnoea syndrome.
Table S2
Quality of non-randomised controlled trials using the Cochrane’s Risk of Bias in Non-
Randomised Controlled Trials (ROBINS-I) assessment tool [35].
Bakker et al. 2014 [1] Fredheim et al. 2013 [2]
Domain 1
Bias due to confounding
Moderate
- Participants chose
their own intervention
Moderate
- Participants chose
their own intervention
Domain 2
Bias in selection of
participants into the study
Low
- Intervention decided
by both participant
and clinician prior to
proceeding with study
Low
- Intervention decided
by both participant
and clinician prior to
proceeding with study
Domain 3
Bias in classification of
interventions
Low
- Interventions were
clearly defined
Moderate
- Possibility that
participants may be
more likely to engage
in intervention (eg.
surgical arm) as
working towards a
goal
Domain 4
Bias due to deviations from
intended interventions
Low Low
- Minimal cross over
Domain 5
Bias due to missing data
Low
- All participant
outcomes were
available
Low
- All participant
outcomes were
available
Domain 6
Bias in measurement of
outcomes
Moderate
- Not mentioned if
sleep scoring
technician was
blinded to the
intervention arm
- Participant
choice/decision may
influence some of the
outcomes measured
Moderate
- Sleep study
recordings were
scored manually by
the same person,
however, this was not
blinded (study
authors scored the
sleep studies when
this was inquired with
the author)
- Outcome assessors
were blinded to the
intervention
Domain 7
Bias in selection of the
reported result
Low
- No multiple outcome
measurements were
made
Moderate
- Skewed data was
performed and log
regression was
conducted to take
into account for
certain factors
Overall Risk of Bias Moderate
- Unpredictable
Moderate
- Unpredictable
Table S3
Quality of randomised controlled trials using the Cochrane Risk of Bias (ROBINS2)
assessment tool [35]. Outcome: Apnoea-hypopnoea index (events/h)
Studies/Domains Dixon et al. 2012
[11]
Feigel-Guiller et al.
2015 [12]
Bakker et al. 2017
[13]
Randomisation
process
Low Low Low
Deviations from
intended
Low Some concerns Some concerns
Missing outcome
data
Low Low Low
Measurement of the
outcome
Low Some concerns Some concerns
Selection of the
reported results
Some concerns Low Low
Overall bias Low Some concerns Some concerns
Table S4
GRADE worksheet
(assessing the
quality of evidence
across studies for an
outcome) of
included studies in
systematic review
and meta-analysis.
[36] Quality criteria
Rating Footnotes Quality
of the
evidence
Primary outcomes (AHI and BMI)
Risk of bias Very
serious
(-2)
Majority are before-and-after studies, variable
inclusion criteria/study design, high drop-out
rate & uncertain on outcome in drop-out
group. For CPAP vs BS study, large cross-
over group.
Inconsistency No All studies had relevant populations,
interventions, comparators and outcomes,
and similar treatment effect whereby all
patients did have weight loss and
improvement in AHI. However, there were
also variable follow-up time points (eg
3mo,6mo, 12mo, 5 y) and at least moderate
heterogeneity despite accounting for time.
Indirectness No All studies did perform a before-and-after
surgery review, which should be able to
address the outcome in question.
Imprecision No Confidence intervals overall did not cross
zero and the results were consistent across
all studies. There were variable sample sizes
(n=8 to 205). We are certain that the
intervention has beneficial outcomes. Very low
Publication Bias Unlikely Funnel plots in general looked symmetrical.
Not confirmed but not enough evidence to
downgrade in this case.
Large effect Large (+1) All studies (large and small) did demonstrate
a significant change in AHI and BMI despite
study design.
Dose-response
gradient
No Not applicable
Plausible
confounding would
change the effect
No Not applicable
AHI: apnoea-hypopnoea index (events/h); BMI: body mass index (kg/m2); BS: bariatric
surgery; CPAP: continuous positive airway pressure.
Table S5
Publication bias statistics – Begg’s and Egger’s test results.
Parameter Begg’s test (p-value) Egger’s test (p-value & 95%CI)
WMD (Change in AHI) 0.166 0.234 (-0.257, 0.068)WMD (Change in BMI) 0.113 0.062 (-0.599, 0.017)WMD (Change in weight) 0.304 0.036 (0.008, 0.189)
AHI: apnoea-hypopnoea index (events/h); BMI: body mass index (kg/m²); CI: confidence interval.
REFERENCES
1. Bakker JP, Campana LM, Montesi SB, Balachandran J, Deyoung PN, Smales E, et al. A pilot study investigating the effects of continuous positive airway pressure treatment and weight-loss surgery on autonomic activity in obese obstructive sleep apnea patients. J Electrocardiol. 2014;47(3):364-73.2. Fredheim JM, Rollheim J, Sandbu R, Hofso D, Omland T, Roislien J, et al. Obstructive sleep apnea after weight loss: a clinical trial comparing gastric bypass and intensive lifestyle intervention. J Clin Sleep Med. 2013;9(5):427-32.3. Peromaa-Haavisto P, Tuomilehto H, Kossi J, Virtanen J, Luostarinen M, Pihlajamaki J, et al. Obstructive sleep apnea: the effect of bariatric surgery after 12 months. A prospective multicenter trial. Sleep Med. 2017;35:85-90.4. Morong S, Benoist LB, Ravesloot MJ, Laman DM, de Vries N. The effect of weight loss on OSA severity and position dependence in the bariatric population. Sleep Breath. 2014;18(4):851-6.5. Cartwright RD. Effect of sleep position on sleep apnea severity. Sleep. 1984;7(2):110-4.6. Lettieri CJ, Eliasson AH, Greenburg DL. Persistence of obstructive sleep apnea after surgical weight loss. J Clin Sleep Med. 2008;4(4):333-8.7. Zou J, Zhang P, Yu H, Di J, Han X, Yin S, et al. Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea in a Chinese Population with Obesity and T2DM. Obes Surg. 2015;25(8):1446-53.8. Xu H, Zhang P, Han X, Yu H, Di J, Zou J, et al. Sex Effect on Obesity Indices and Metabolic Outcomes in Patients with Obese Obstructive Sleep Apnea and Type 2 Diabetes After Laparoscopic Roux-en-Y Gastric Bypass Surgery: a Preliminary Study. Obes Surg. 2016;26(11):2629-39.9. Shaarawy H, Sarhan A, A ELH. Assessment of the effect of bariatric surgery on severe obstructive sleep apnea patients not tolerating CPAP therapy. Egyptian Journal of Chest Diseases and Tuberculosis. 2016;65(3):661-6.10. Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castano VA, et al. Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg. 2004;14(6):755-62.11. Dixon J, Schachter L, O'Brien P, Jones K, Grima M, Lambert G, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. Jama [Internet]. 2012; 308(11):[1142-9 pp.]. Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/684/CN-00832684/frame.html.12. Feigel-Guiller B, Drui D, Dimet J, Zair Y, Le Bras M, Fuertes-Zamorano N, et al. Laparoscopic Gastric Banding in Obese Patients with Sleep Apnea: A 3-Year Controlled Study and Follow-up After 10 Years. Obes Surg. 2015;25(10):1886-92.13. Bakker JP, Tavakkoli A, Rueschman M, Wang W, Andrews R, Malhotra A, et al. Gastric Banding Surgery versus CPAP for Obstructive Sleep Apnea: A Randomized Controlled Trial. Am J Respir Crit Care Med. 2017.14. Drager LF, Brunoni AR, Jenner R, Lorenzi-Filho G, Bensenor IM, Lotufo PA. Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax. 2015;70(3):258-64.15. Boyd SB, Upender R, Walters AS, Goodpaster RL, Stanley JJ, Wang L, et al. Effective Apnea-Hypopnea Index ("Effective AHI"): A New Measure of Effectiveness for Positive Airway Pressure Therapy. Sleep. 2016;39(11):1961-72.16. Sutherland K PC, Cistulli PA. Efficacy versus effectiveness in the treatment of obstructive sleep apnea: CPAP and oral appliances. Journal of Dental Sleep Medicine. 2015;2(4):175-81.17. Vanderveken OM, Dieltjens M, Wouters K, De Backer WA, Van de Heyning PH, Braem MJ. Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing. Thorax. 2013;68(1):91-6.
18. U.S. Department of Health & Human Services National Heart L, and Blood Institute. Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group. 2014.19. Aguiar I, Freitas W, Santos I, Apostolico N, Nacif S, Urbano J, et al. Obstructive sleep apnea and pulmonary function in patients with severe obesity before and after bariatric surgery: A randomized clinical trial. Multidisciplinary Respiratory Medicine [Internet]. 2014; 9(1) (no pagination). Available from: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/536/CN-01128536/frame.html.20. Bae EK, Lee YJ, Yun CH, Heo Y. Effects of surgical weight loss for treating obstructive sleep apnea. Sleep Breath. 2014;18(4):901-5.21. da Silva RP, Martinez D, Faria CC, de Carli LA, de Souza WI, Meinhardt NG, et al. Improvement of exercise capacity and peripheral metaboreflex after bariatric surgery. Obes Surg. 2013;23(11):1835-41.22. Del Genio G, Limongelli P, Del Genio F, Motta G, Docimo L, Testa D. Sleeve gastrectomy improves obstructive sleep apnea syndrome (OSAS): 5 year longitudinal study. Surg. 2016;12(1):70-4.23. de Raaff CA, Coblijn UK, Ravesloot MJ, de Vries N, de Lange-de Klerk ES, van Wagensveld BA. Persistent moderate or severe obstructive sleep apnea after laparoscopic Roux-en-Y gastric bypass: which patients? Surg. 2016;12(10):1866-72.24. Dixon JB, Schachter LM, O'Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes (Lond). 2005;29(9):1048-54.25. Fritscher LG, Canani S, Mottin CC, Fritscher CC, Berleze D, Chapman K, et al. Bariatric surgery in the treatment of obstructive sleep apnea in morbidly obese patients. Respiration. 2007;74(6):647-52.26. Guardiano SA, Scott JA, Ware JC, Schechner SA. The long-term results of gastric bypass on indexes of sleep apnea. Chest. 2003;124(4):1615-9.27. Haines KL, Nelson LG, Gonzalez R, Torrella T, Martin T, Kandil A, et al. Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery. 2007;141(3):354-8.28. Krieger AC, Youn H, Modersitzki F, Chiu YL, Gerber LM, Weinshel E, et al. Effects of laparoscopic adjustable gastric banding on sleep and metabolism: A 12-month follow-up study. International Journal of General Medicine. 2012;5:975-81.29. Pallayova M, Steele KE, Magnuson TH, Schweitzer MA, Smith PL, Patil SP, et al. Sleep apnea determines soluble TNF-alpha receptor 2 response to massive weight loss. Obes Surg. 2011;21(9):1413-23.30. Priyadarshini P, Singh VP, Aggarwal S, Garg H, Sinha S, Guleria R. Impact of bariatric surgery on obstructive sleep apnoea–hypopnea syndrome in morbidly obese patients. Journal of Minimal Access Surgery. 2017;13(4):291-5.31. Rao A, Tey BH, Ramalingam G, Poh AG. Obstructive sleep apnoea (OSA) patterns in bariatric surgical practice and response of OSA to weight loss after laparoscopic adjustable gastric banding (LAGB). Ann Acad Med Singapore. 2009;38(7):587-7.32. Ravesloot MJ, Hilgevoord AA, van Wagensveld BA, de Vries N. Assessment of the effect of bariatric surgery on obstructive sleep apnea at two postoperative intervals. Obes Surg. 2014;24(1):22-31.33. Suliman LAM, Abdalla DA. Does sleeve gastrectomy improve obstructive sleep apnea? Egyptian Journal of Chest Diseases and Tuberculosis. 2016;65(2):505-10.34. Xie H, Doherty L, O'Boyle C. The Positive Impact of Bariatric Surgery on Sleep. Ir Med J. 2016;109(1):328-30.35. Higgins JPT, Green, S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011.36. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology.64(4):401-6.